Prof. Sireen Abdulrahim Shilbayeh | Clinical Pharmacy | Best Researcher Award

Professor Sireen Abdulrahim Shilbayeh is a distinguished academic in clinical pharmacy with over two decades of experience in teaching, research, and healthcare practice. She earned her Ph.D. in Clinical Pharmacy Practice from the University of Nottingham, UK, specializing in pharmaceutical and health outcomes research, particularly the meta-analysis of antiarrhythmic drug trials. Currently a professor at Princess Nourah University in Riyadh, Saudi Arabia, she has held several key academic and administrative roles, including department head and scientific committee member. Her core strengths include evidence-based clinical practice, curriculum development, and interprofessional collaboration. She has been recognized with multiple institutional awards for research excellence and productivity. Her scholarly contributions span clinical trials, systematic reviews, and pharmacy education, supported by active participation in international conferences. Professor Shilbayeh is committed to advancing pharmacy practice through impactful research, academic leadership, and the mentoring of future healthcare professionals.

Professional Profile 

Google Scholar
Scopus Profile 

Strengths for the Award

Professor Shilbayeh demonstrates a distinguished and consistent record of academic and research achievements. Her doctoral training from the University of Nottingham, UK, focused on high-impact, evidence-based clinical pharmacy research, particularly in meta-analysis and systematic reviews—areas that are fundamental to improving clinical decision-making and healthcare outcomes.

Her long-standing academic trajectory, progressing from Assistant to Full Professor, across multiple universities, reflects both resilience and recognition of her scholarly contributions. She has served in prestigious roles, including chair memberships in university scientific councils and IRB committees, indicating peer trust and leadership in research governance.

Further, she has received multiple awards for research excellence from Princess Nourah University, particularly for prolific output in health sciences—a strong testament to her research productivity and impact. Her work on antiarrhythmic drug evaluations and pharmacoepidemiology, combined with over two decades of conference participation, showcases her dedication to scientific dissemination and continuing professional development.

 Education

Professor Sireen Abdulrahim Shilbayeh holds a strong academic foundation in pharmaceutical sciences. She began her studies at King Saud University in Riyadh, Saudi Arabia, where she earned her Bachelor’s degree in Pharmacy. Seeking to further her education, she pursued postgraduate studies at the University of Nottingham in the United Kingdom. There, she completed an MPhil in Clinical Pharmacy, focusing on systematic reviews of clinical trials, followed by a Ph.D. in Clinical Pharmacy Practice. Her doctoral research specialized in the meta-analysis of randomized clinical trials involving antiarrhythmic drugs, combining rigorous scientific methodology with practical clinical implications. Throughout her academic journey, she developed a comprehensive understanding of clinical pharmacy, pharmacoepidemiology, and pharmaceutical care. Her education has been instrumental in shaping her evidence-based research approach, teaching philosophy, and ability to lead complex projects in academia and healthcare. These qualifications have paved the way for her successful academic and professional career in the region and beyond.

 Experience

Professor Shilbayeh brings over 25 years of academic and clinical experience in pharmacy. She began her professional career as a pharmacist at King Khaled University Hospital in Riyadh, gaining hands-on experience in inpatient and outpatient services, IV preparation, and drug information. She later worked as a clinical researcher at Nottingham University Hospital, focusing on cardiovascular pharmacotherapy. Her academic journey includes positions at Applied Science University and Al-Zytoonah University in Jordan, where she progressed from Assistant to Associate Professor. Since 2010, she has been affiliated with Princess Nourah University, where she became a Full Professor in 2015. Beyond teaching, she has served in several administrative capacities, including Head of the Clinical Pharmacy Practice Department, and as a member of the Institutional Review Board, Scientific Council, and Development Committees. Her career is marked by a blend of teaching excellence, research leadership, and a commitment to advancing clinical pharmacy education and healthcare practices.

🏅Awards and Honors

Professor Sireen Shilbayeh has received multiple accolades recognizing her contributions to research and academia. Among her most notable honors is the Excellence in Research Productivity Award from Princess Nourah University, awarded across all health-related faculties. This prestigious recognition highlights her extensive research output and impact within the healthcare sector. Additionally, she received an Appreciation Award from the University’s Graduate and Research Agency for her distinguished publications in indexed international journals. These awards reflect her dedication to scholarly excellence, continuous engagement with high-quality research, and leadership within the academic community. Her ability to maintain consistent output while supporting academic development and policy initiatives has earned her widespread respect. These honors also serve as acknowledgment of her commitment to raising standards in pharmacy practice and education, both regionally and internationally. Her achievements continue to inspire colleagues and students, solidifying her reputation as a leading figure in clinical pharmacy research.

Research Focus on Clinical Pharmacy

Professor Shilbayeh’s research centers on clinical pharmacy practice, with a strong emphasis on evidence-based medicine, pharmaceutical care, and health outcomes research. Her early work, including her doctoral dissertation, focused on the meta-analysis of antiarrhythmic drug trials, contributing valuable insights into cardiology-related pharmacotherapy. She is deeply involved in systematic reviews, pharmacoepidemiology, and comparative effectiveness research, ensuring her findings have direct clinical relevance. Her scholarly interests also span patient-centered care, drug safety, and therapeutic decision-making, aiming to improve the quality and efficiency of healthcare delivery. She frequently collaborates on projects addressing chronic disease management and clinical interventions in pharmacy practice. Through her work on the Institutional Review Board, she contributes to research ethics and the development of robust study designs. Her research not only informs clinical practice but also plays a key role in curriculum development and training for future pharmacists, emphasizing scientific rigor and real-world application.

 Publications Top Notes

• Title: Prevalence of osteoporosis and its reproductive risk factors among Jordanian women: a cross-sectional study
  Authors: S. Shilbayeh
  Year: 2003
  Citations: 114

• Title: Exploring knowledge and attitudes towards counselling about vitamin supplements in Jordanian community pharmacies
  Authors: S.A. Shilbayeh
  Year: 2011
  Citations: 42

• Title: Validation of knowledge and adherence assessment tools among patients on warfarin therapy in a Saudi hospital anticoagulant clinic
  Authors: S.A.R. Shilbayeh, W.A. Almutairi, S.A. Alyahya, N.H. Alshammari, E. Shaheen, et al.
  Year: 2018
  Citations: 40

• Title: University students’ knowledge, attitudes, and practices towards the national premarital screening program of Saudi Arabia
  Authors: M. Melaibari, S. Shilbayeh, A. Kabli
  Year: 2017
  Citations: 35

• Title: Does COVID-19 lockdowns have impacted on global dengue burden? A special focus to India
  Authors: H. Sharma, A. Ilyas, A. Chowdhury, N.K. Poddar, A.A. Chaudhary, et al.
  Year: 2022
  Citations: 29

• Title: The impact of CYP3A5 and MDR1 polymorphisms on tacrolimus dosage requirements and trough concentrations in pediatric renal transplant recipients
  Authors: S. Shilbayeh, R. Zmeili, R.I. Almardini
  Year: 2013
  Citations: 22

• Title: A Markov Chain Model to Evaluate the Effect of CYP3A5 and ABCB1 Polymorphisms on Adverse Events Associated with Tacrolimus in Pediatric Renal Patients
  Authors: S.K.B. Sy, J. Heuberger, S. Shilbayeh, D.J. Conrado, H. Derendorf
  Year: 2013
  Citations: 19

• Title: Pediatric renal transplantation in the Jordanian population: the clinical outcome measures during long-term follow-up period
  Authors: S. Shilbayeh, I. Hazza
  Year: 2012
  Citations: 17

• Title: Quantitation of the impact of CYP3A5 A6986G polymorphism on quetiapine pharmacokinetics by simulation of target attainment
  Authors: S.A.R. Shilbayeh, S.K.B. Sy, M. Melhem, R. Zmeili, H. Derendorf
  Year: 2015
  Citations: 14

• Title: Possible interethnic differences in omeprazole pharmacokinetics: comparison of Jordanian Arabs with other populations
  Authors: S. Shilbayeh, M.F. Tutunji
  Year: 2006
  Citations: 14

• Title: Treatment satisfaction questionnaire for medication: validation of the translated Arabic version among patients undergoing warfarin therapy in Saudi Arabia
  Authors: S.A.R. Shilbayeh, S.A. Alyahya, N.H. Alshammari, W.A. Almutairi, E. Shaheen
  Year: 2018
  Citations: 10

• Title: The impact of genetic polymorphisms on time required to attain the target tacrolimus levels and subsequent pharmacodynamic outcomes in pediatric kidney transplant patients
  Authors: S. Shilbayeh
  Year: 2014
  Citations: 10

• Title: Influence of CYP3A5 6986A > G and ABCB1 3435C > T Polymorphisms on Adverse Events Associated With Tacrolimus in Jordanian Pediatric Renal Patients
  Authors: S.K.B. Sy, R.P. Singh, S. Shilbayeh, R. Zmeili, D. Conrado, H. Derendorf
  Year: 2013
  Citations: 9

• Title: The anti-clot treatment scale (ACTS): validation of the translated Arabic version among patients undergoing warfarin therapy in Saudi Arabia
  Authors: S.A.R. Shilbayeh, A.A. Ibrahim
  Year: 2020
  Citations: 7

• Title: Patient experience with an educational mobile health application: A pilot study on usability and feasibility in a Saudi population
  Authors: I.S.A. Shilbayeh, S.A. Shilbayeh
  Year: 2020
  Citations: 7

🏁 Conclusion